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assay using flow cytometry. Data analysis was done using the
software CellQuestPro.
Results and discussions Our study results demonstrated that
the methanol extract of Holothuria scabra exhibited cytotoxic
activity through inhibiting the growth of T47D cancer cells in
a dose-dependent manner, start from 50 mg/mL until 500 mg/
mL, with IC50 value of 152.98 mg/mL. The methanol extract
of Holothuria scabra was able to stimulate 99% cancer cells
to undergo apoptosis. This data warrant for further investiga-
tion on that apoptotic mechanism. The investigation is impor-
tant to support cancer therapeutical strategies that focus on
inducing cell death to overcome apoptosis resistance, one of
the most important hallmark of cancer.
Conclusion The methanol extract of Holothuria scabra con-
tains a promising anti-cancer agent that possesses cytotoxic
and apoptotic effects on breast cancer cells.
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Introduction Cancer cells escape immune system surveillance by
activating molecules called ‘immune checkpoints’, of which pro-
grammed death-1 (PD-1) and programmed death ligand-1 (PD-
L1) are known representative molecules. Immune cells do not
become active when the PD-1 present on their cell surface recog-
nises the PD-L1 present on a cancer cell’s surface, allowing can-
cer cells to evade the immune cell’s attack. Immune checkpoint-
blocking antibodies developed to target PD-1/PD-L1 have
remarkable anti-cancer activity. However, the biological reasons
why cancer cells activate PD-L1 remain unclear. In addition,
there is an issue with cells, such as myocardial cells, with PD-L1
present on their cell surfaces also being affected by immune
checkpoint-blocking antibodies. We focused on a signal peptide
of PD-1 expressed on the immune cell surface. Our hypothesis
was that the signal peptide produced as part of the production
process that leads to mature PD-1 has an anti-tumour function.
We evaluated whether an artificial peptide designed based on
this PD-1 signal peptide had cell growth inhibition activity
against human melanoma A2058 and non-small cell lung cancer
(NSCLC) HCC-827.
Material and methods We chemically synthesised a conjugation
peptide of the human PD-1 signal peptide (MQIPQAPWPVV-
WAVLQLGWR) and a cell penetrating peptide TAT
(RRKKRRQRRR) and named it ‘PD1SP-TAT’ (MQIP-
QAPWPVVWAVLQLGWRRRKKRRQRRR). PD1SP-TAT was
evaluated for growth inhibitory activity against A2058 and
HCC-827 by WST assay.
Results and discussions The results were 95% of human mela-
noma A2058 growth and NSCLC HCC-827 growth were
inhibited in cells treated with a concentration of 25 mM
PD1SP-TAT for 48 hours.
Conclusion From these surprising results, PD1SP-TAT, based
on the signal peptide of PD-1, shows remarkable anti-cancer
activity against human melanoma and NSCLC, and suggests
that PD1SP-TAT could be a candidate for a novel anti-cancer
agent.
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Introduction Nanoparticles (NPs) are increasingly used in cancer
therapy as delivery agents and in the diagnosis of malignant dis-
eases as contrast agents for magnetic resonance imaging (MRI).
The aim of this work was in vitro assessments of Gd-NPs, Fe-
NPs, CoFe-NPs and Graphene Oxide-NPs cytotoxicity and geno-
toxicity on some tumour and normal human cell lines.
Material and methods The investigated new nanomaterials
were prepared and characterised by standard methods XRD,
FTIR, SEM, TEM, AFM and MR relaxometry measurements.
Cytotoxic activity of investigated compounds was performed
by 72 hour MTT test. Target cells used were MDA-MB-453,
HeLa and K562 malignant cells and MRC-5 was used as nor-
mal control cells. Genotoxicity of Gd-NP was evaluated by
the Comet assay on the model of normal MRC-5 cells. DNA
strand break levels were determined and expressed as% tail
DNA.
Results and discussions All investigated nanoparticle materials
exerted a dose dependent cytotoxicity towards investigated cell
lines with moderate to low selectivity in their action to
tumour cells in comparison to normal control cells. Concen-
trations inducing 50% decrease in cell survival (IC50) showed
that Gd-NPs possess moderate cytotoxicity and selectivity with
IC50 value of 297 mg/mL on K562 cells and IC50=740 mg/mL
for control MRC-5 cells. Likewise, Fe-NPs did not show tox-
icity on normal MRC-5 cells (IC50 >1000 mg/mL), but possess
moderate toxicity to all tumour cells (IC50=336 mg/mL,
406 mg/mL and 682 mg/mL for K562, MDA-MB-453 and
HeLa cells respectively). Graphene oxide-NPs showed very
strong toxicity to all investigated cell lines and low selectivity
with IC50 values in the range of 2.13 mg/mL (K562 cells) to
3.30 mg/mL (control MRC-5 cells). CoFe-NPs also showed
strong toxicity, but to a lesser extent compared to graphene
oxide (the IC50 values for all tested cell lines were in the
range 19–40 mg/mL).Evaluation of genotoxicity by the Comet
assay after treatment of MRC-5 cells with Gd-NPs showed no
effect on DNA strand break levels at doses up to 750 mg/ml.
The DNA is damaged only at very high concentrations applied
(1125 mg/mL).
Conclusion Results obtained showed that Graphene Oxide-NPs
and CoFe-NPs have very strong nonselective toxicity, but
gadolinium and Fe nanomaterials due to a moderate selectivity
in toxicity to tumour cells could be promising agents for fur-
ther research and the use in the diagnostics and treatment of
cancers.
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